Megan Frisk, PhD

Dr. Megan Frisk is the Chief Strategy Officer at Vigilance, a division of Alloy Therapeutics focused on biosecurity and rapid therapeutic response to emerging biological threats. Prior to joining Alloy, she served as the Chief of Staff and inaugural Director for International Affairs at the Advanced Research Projects Agency for Health (ARPA-H). Megan’s career in the U.S. government includes roles as Senior Advisor to the Special Envoy for Critical & Emerging Technology at the U.S. Department of State; Director for Biotechnology Risk and Biological Weapons Nonproliferation at the White House National Security Council (NSC); and AAAS Science & Technology Policy Fellow in the Office of the Science & Technology Adviser to the Secretary of State. During her tenure at the State Department, she also managed bilateral science and technology relations, research integrity and security policy, and biosecurity policy. Megan brings experience in scientific publishing as well, having served as Senior Editor at Science Translational Medicine and Editor of Trends in Biotechnology. She earned her Ph.D. in Analytical Chemistry from the University of Wisconsin-Madison and her B.S. in Biochemistry from the University of Virginia.